Validity and utility of the University of Texas M. D. Anderson Symptom Inventory (MDASI) among prostate cancer patients: Data from E2Z02: Symptom Outcomes and Practice Patterns (SOAPP).

被引：0
|
作者：
Patrick-Miller, Linda J.
Zhao, Fengmin
Cleeland, Charles S.
Wagner, Lynne I.
Fisch, Michael
Mendoza, Tito R.
机构：
[1] Univ Chicago, Ctr Clin Canc Genet, Chicago, IL 60637 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Northwestern Univ, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15173
引用
收藏
页数：1
相关论文
共 15 条
  • [1] Validity and utility of the M. D. Anderson Symptom Inventory (MDASI) among prostate cancer patients: data from E2Z02: symptom outcomes and practice patterns (SOAPP)
    Mendoza, Tito R.
    Zhao, Fengmin
    Patrick-Miller, Linda J.
    Cleeland, Charles S.
    Wagner, Lynne I.
    Fisch, Michael
    QUALITY OF LIFE RESEARCH, 2012, 21 : 16 - 16
  • [2] Patterns of antidepressant use in patients with cancer: An analysis from SOAPP (E2Z02: Symptom Outcomes and Practice Patterns)
    Fisch, Michael
    Zhao, Fengmin
    Manola, Judith
    Miller, Andrew H.
    Pirl, William F.
    Wagner, Lynne I.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [3] The Validity and Utility of the M. D. Anderson Symptom Inventory in Patients With Breast Cancer: Evidence From the Symptom Outcomes and Practice Patterns Data From the Eastern Cooperative Oncology Group
    Mendoza, Tito R.
    Zhao, Fengmin
    Cleeland, Charles S.
    Wagner, Lynne I.
    Patrick-Miller, Linda J.
    Fisch, Michael J.
    CLINICAL BREAST CANCER, 2013, 13 (05) : 325 - 334
  • [4] The Validity and Utility of the MD Anderson Symptom Inventory in Patients With Prostate Cancer: Evidence From the Symptom Outcomes and Practice Patterns (SOAPP) Data From the Eastern Cooperative Oncology Group
    Jones, Desiree
    Zhao, Fengmin
    Fisch, Michael J.
    Wagner, Lynne I.
    Patrick-Miller, Linda J.
    Cleeland, Charles S.
    Mendoza, Tito R.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (01) : 41 - 49
  • [5] Patterns of antidepressant use in cancer patients (pts): An analysis from SOAPP (ECOG E2Z02: Symptom Outcomes and Practice Patterns)
    Manola, Judith
    Zhao, Fengmin
    Miller, Andrew H.
    Pirl, William F.
    Wagner, Lynne I.
    Fisch, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer
    Sailors, Mary H.
    Bodurka, Diane C.
    Gning, Ibrahima
    Ramondetta, Lois M.
    Williams, Loretta A.
    Mendoza, Tito R.
    Agarwal, Sonika
    Sun, Charlotte C.
    Cleeland, Charles S.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (02) : 323 - 328
  • [7] Measuring the Symptom Burden of Lung Cancer: The Validity and Utility of the Lung Cancer Module of the M. D. Anderson Symptom Inventory (MDASI-LC)
    Mendoza, Tito R.
    Wang, Xin Shelley
    Palos, Guadalupe
    Lu, Charles
    Liao, Zhongxing
    Mobley, Gary
    Kapoor, Shitij
    Cleeland, Charles S.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 18 - 18
  • [8] Utility of the of the M. D. Anderson Symptom Assessment Inventory (MDASI) for symptom evaluation during chemoradiation (CRT) in patients with gastrointestinal malignancies
    Janjan, N. A.
    Wang, X. S.
    Mendoza, T.
    Zhang, Y.
    Das, P.
    Crane, C.
    Delclos, M.
    Krishnan, S.
    Cleeland, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Greek M. D. Anderson Symptom Inventory: Validation and utility in cancer patients
    Mystakidou, K
    Cleeland, C
    Tsilika, E
    Katsouda, E
    Primikiri, A
    Parpa, E
    Vlahos, L
    Mendoza, T
    ONCOLOGY, 2004, 67 (3-4) : 203 - 210
  • [10] Measuring the Symptom Burden of Lung Cancer: The Validity and Utility of the Lung Cancer Module of the M. D. Anderson Symptom Inventory
    Mendoza, Tito R.
    Wang, Xin Shelley
    Lu, Charles
    Palos, Guadalupe R.
    Liao, Zhongxing
    Mobley, Gary M.
    Kapoor, Shitij
    Cleeland, Charles S.
    ONCOLOGIST, 2011, 16 (02): : 217 - 227
12